Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinoma.
第一作者:
Seulki,Cho
第一单位:
Department of Functional Genomics, University of Science & Technology, Daejeon, Republic of Korea.
作者:
主题词
动物(Animals);抗体, 单克隆(Antibodies, Monoclonal);胆管肿瘤(Bile Duct Neoplasms);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);胆管上皮癌(Cholangiocarcinoma);顺铂(Cisplatin);脱氧胞苷(Deoxycytidine);疾病模型, 动物(Disease Models, Animal);人类(Humans);小鼠(Mice);分子靶向治疗(Molecular Targeted Therapy);神经细胞黏附分子L1(Neural Cell Adhesion Molecule L1);组织分布(Tissue Distribution);肿瘤负荷(Tumor Burden);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1371/journal.pone.0170078
PMID
28166242
发布时间
2022-12-07
- 浏览17

PloS one
e0170078页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文